Skip to content
Trial Eligibility
Menu

Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project

NCT02434393

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this research study is to characterize the mechanisms contributing to cognitive impairment and accelerated cognitive decline in Late Life Depression (LLD). This is a non-randomized, observational, non-treatment study that originally launched in 2015, enrolling 133 participants. From the originally enrolled participants, the continuation of the ADNI-D study will enroll 120 participants which will include following participants from the original (parent) protocol and enrollment of new participants for a period of 30 months.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Major Depression
  • Late Life Depression (LLD)

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
65 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
University of Southern California
Last updated on ClinicalTrials.gov
November 25, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • University of California, San Francisco · San Francisco, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.